Lexicon Pharmaceuticals I...

NASDAQ: LXRX · Real-Time Price · USD
0.72
0.06 (8.91%)
At close: Jun 05, 2025, 3:59 PM
0.73
1.65%
After-hours: Jun 05, 2025, 07:58 PM EDT
8.91%
Bid 0.7
Market Cap 260.11M
Revenue (ttm) 31.21M
Net Income (ttm) -177.3M
EPS (ttm) -0.5
PE Ratio (ttm) -1.43
Forward PE -2.03
Analyst Hold
Ask 0.74
Volume 7,743,906
Avg. Volume (20D) 13,954,607
Open 0.67
Previous Close 0.66
Day's Range 0.66 - 0.77
52-Week Range 0.28 - 2.45
Beta 1.01

About LXRX

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LXRX
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for LXRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
3 weeks ago
-15.57%
Lexicon Pharmaceuticals shares are trading lower a... Unlock content with Pro Subscription
2 months ago
+64.13%
Lexicon Pharmaceuticals shares are trading higher after the company announced an exclusive license agreement with Novo Nordisk for LX9851.